OR WAIT null SECS
© 2023 MJH Life Sciences™ and Diagnostic Imaging. All rights reserved.
Here's what to expect this week on Diagnostic Imaging.
In this week’s preview, here are some highlights of what you can expect to see coming soon:
Imaging plays a key role in oncology care, but, to date, it has been relegated to diagnosis and detection. However, providers are actively investigating how artificial intelligence can augment the impact imaging can have. Recent work is looking not only at screening and detection, but also diagnosis and risk stratification, tumor segmentation, precision oncology, and prognosis prediction and treatment assessment. Look for an article this week based on findings published in Clinical Radiology.
For more coverage of oncology imaging, click here.
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter here.
Peer review has been widely used as a tactic for identifying diagnostic errors and opportunities for improvement. However, it has fallen short of its goal of helping radiologists learn from mistakes. Consequently, the specialty is shifting toward peer learning – a strategy that allows for anonymous critique of diagnostic oversights and gives providers guidance to avoid future errors. This week, look for an interview with Regan City, director of National Sub-speciality Divisions and Patient Safety Organization with RadPartners, about how facilities and institutions can implement their own peer learning models.
For additional articles on RadPartners, click here.
Molecular imaging is becoming more important in differentiating between active joint inflammation and chronic joint damage seen in patients with rheumatic disorders. These advancements can, potentially, impact how providers evaluate treatment responses. Keep an eye open for an article later this week based on findings from the European Journal of Radiology on what’s coming with CT and MRI in musculoskeletal imaging.
For other articles on musculoskeletal imaging, click here.